Delcath Systems Inc. (DCTH, $5.00, +$0.18, +3.73%), a medical-technology company testing a treatment system for primary and metastatic cancers to the liver, ...
... in cancer treatment. The Company is testing a proprietary, patented drug delivery system for the treatment of primary and metastatic liver cancers. ...
When colorectal cancer metastasizes (spreads to other parts of the body such as the liver) chemotherapy is commonly used. Treatment of patients with ...
This process is referred to as metastasis. Metastases are the major cause of death from cancer. -- Some key risk factors for cancer that can be avoided ...
We designed our trial to include patients most likely to benefit from our treatment, and specifically excluded patients with brain or liver metastases, ...
Treatment with lapatinib has also been associated with decreased heart function, liver damage, and inflammation of lung tissue, the agency cautioned. ...
... in cancer treatment. The Company is testing a proprietary, patented drug delivery system for the treatment of primary and metastatic liver cancers. ...
The findings of an ongoing Phase I/II study in previously untreated pancreatic cancer patients with advanced, mostly metastatic, disease involved a ...
Several malignancies and even benign processes are amenable to ablation (ie, hepatocellular carcinoma, lung cancer, liver metastasis from colorectal ...
